Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIERE.L Regulatory News (IERE)

  • There is currently no data for IERE

Result Of Second EGM

29 Dec 2009 12:05

RNS Number : 7716E
Invista European Real Estate Trust
29 December 2009
Β 

ο»Ώ

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FORΒ SALEΒ INCLUDING IN THE UNITEDΒ STATES,Β AUSTRALIA,Β CANADA,Β  JAPAN,Β NEW ZEALANDΒ ORΒ SOUTH AFRICA.Β 

29Β DecemberΒ 2009

INVISTAΒ EUROPEAN REAL ESTATE TRUST SICAF

("IERET" or the "Company")

Results of Second EGM

Β 

IERETΒ today announces that all of the resolutions proposedΒ at theΒ SecondΒ ExtraordinaryΒ General Meeting ('EGM') held today were duly passed.

Β 

Application has been made for theΒ 145,685,674Β New Ordinary Shares,Β 29,137,134Β newΒ Preference Shares andΒ 29,137,134Β newΒ WarrantsΒ to be admitted to trading on theΒ London Stock ExchangeΒ and dealings are expected to commence onΒ 30 December 2009.

Β 

Placing statistics

Offer Price per New Ordinary Share

Β£0.20

Offer Price per Preference Share (with one Warrant attached)

Β£1.00

Exercise price of Warrant

Β£0.29

Total Number of Ordinary Shares in issue post Admission

259,948,949

Number of Preference Shares in issue immediately following Admission

29,137,134

Number of Warrants in issue immediately following Admission

29,137,134

Proceeds of the Placing receivable by the Company before expenses

Β£58.27m

Expected proceeds of the Placing receivable by the Company after expenses

Β£53.51m

Β 

Terms set out in this announcement but not defined are as defined in theΒ Prospectus dated 16 November 2009.

Β 

Tom Chandos, ChairmanΒ of the Invista European Real Estate Trust, commented:

"We are very pleased with theΒ take-up we have seen for this capital raise fromΒ both new andΒ existing shareholdersΒ which,Β together withΒ the passing of the EGM resolutions,Β demonstrates the strength of support for the Company's strategy.Β 

"TheΒ strengthened financial position following the Capital Raising and the subsequent amendment which willΒ nowΒ be made to the terms of the Bank of Scotland Facility, placeΒ the CompanyΒ on a more stableΒ financial footing and positionΒ itΒ wellΒ to create and enhance future value for allΒ ofΒ our shareholders."

-ENDS-

For further information:

Invista Real EstateΒ 

Tony Smedley/Chris Ludlam

Tel:Β +44 20 7153 9369

J.P. Morgan CazenoveΒ LimitedΒ (Joint Sponsor, Joint Financial Adviser andΒ Joint Bookrunner)

William Simmonds

Tel: +44 20 7588 2828

Liberum CapitalΒ LimitedΒ (Joint Sponsor, Joint Financial Adviser and Joint Bookrunner)

Chris Bowman / Tom Fyson

Tel: +44Β 20 3100 2000

Financial Dynamics

Stephanie HighettΒ /Β Rachel Drysdale/ Olivia GoodallΒ Β 

Tel: +44 20 7831 3113

realestate@fd.com

This announcementΒ isΒ an advertisement and is not a prospectus. Accordingly, investors should not subscribe for securities except on the basis of information in the Prospectus itself.

Neither this document nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Any offer to acquire securities pursuant to the Capital Raising will be made, and any investor should make his investment, solely on the basis of information that is contained in the Prospectus.Β Copies of the Prospectus may be obtained at no cost from the Company's website (www.ieret.eu).

This announcement and the information contained herein is not for publication, release or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, New Zealand, South Africa or any jurisdiction in which the same would be unlawful. This announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or acquire shares in the capital of the Company in the United States, Australia, Canada, Japan, New Zealand, South Africa or any jurisdiction in which such an offer or solicitation is unlawful.

Any offering will only be made in any jurisdiction in compliance with local laws. In anyΒ RelevantΒ MemberΒ State, this communication is only addressed to and is only directed at qualified investors in thatΒ MemberΒ StateΒ within the meaning of the Prospectus Directive (and it is only so addressed or directed to the extent permitted by all other applicable laws and regulations).

This communication is directed only at (i) persons outside the United Kingdom, or (ii) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth companies, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) (a) to (d) of the Order. Persons within theΒ United KingdomΒ who receive this communication (other than persons falling within (ii) and (iii) above) should not rely on or act upon this communication.

No representation or warranty, express or implied, is made or given by, or on behalf of J.P. Morgan Cazenove or Liberum Capital or any of their respective members, directors, officers, employees or advisers or any other person as to the accuracy or completeness of theΒ information or opinions contained in this communication and no responsibility or liability is accepted by any of them for any such information or opinions. You should note that, in connection with the proposed Capital Raising, J.P. Morgan Cazenove and Liberum Capital, each of which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for the Company and are neither advising nor treating as a client any other person and will not be responsible to anyone other than the Company for providing the protections afforded to clients of J.P. Morgan Cazenove and Liberum Capital or for providing advice in relation to the proposed Capital Raising.

Neither this communication nor any copy of it, may be taken, transmitted or distributed, directly or indirectly, into the United States of America, its territories or possessions or passed to United States residents, corporations or other entities organised under the laws of the United States or any State thereof or any US branch, agency or affiliate of any such corporation or entity, wherever located except pursuant to applicable exemptions. Neither this communication nor any copy hereof may be distributed in theΒ ExcludedΒ TerritoriesΒ or in any other jurisdiction where its distribution may be restricted by law and persons into whose possession this communication comes should inform themselves about, and observe, any such restrictions. Distribution of this communication in theΒ United States, or any such other jurisdictions, except in accordance with applicable exemptions may constitute a violation ofΒ United StatesΒ securities laws, or the law of any such other jurisdictions.

The Offer Shares and Warrants have not been and will not be registered under the US Securities Act or with any securities regulatory authority of any state or other jurisdiction of theΒ United States. The Offer Shares and Warrants are being offered and sold only outside theΒ United StatesΒ to investors that are not US Persons in "offshore transactions" in accordance with and in reliance on the exemption from registration provided by Regulation S. The Offer Shares and Warrants may not be offered or sold within theΒ United StatesΒ or to, or for the account or benefit of, US Persons. The Company will not be registered under the US Investment Company Act and investors will not be entitled to the benefits of such Act. The Offer Shares and Warrants have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission in the United States or any other regulatory authority, nor have or will any of the foregoing authorities passed upon or endorsed the merits of the offering of Offer Shares and Warrants or the accuracy or adequacy of the Prospectus. Any representation to the contrary is a criminal offence in theΒ United States.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
REGGGMZZZLFGLZM
Date   Source Headline
28th Mar 20142:05 pmRNSResult of AGM
11th Mar 20144:06 pmRNSHolding(s) in Company
3rd Mar 201411:03 amRNSHolding(s) in Company
21st Feb 20147:00 amRNSAnnouncement of NAV and IMS
18th Feb 20141:12 pmRNSSale Completion of One Asset in Czech Republic
17th Feb 201410:07 amRNSHolding(s) in Company
3rd Feb 20144:40 pmRNSSecond Price Monitoring Extn
3rd Feb 20144:35 pmRNSPrice Monitoring Extension
31st Jan 20143:56 pmRNSFull Year Results
31st Jan 20143:54 pmRNSInterim Management Statement
28th Jan 20143:04 pmRNSWarrants
16th Jan 20147:00 amRNSOver-Amortization of Debt
14th Jan 20142:50 pmRNSHolding(s) in Company
23rd Dec 20137:00 amRNSExtension of Debt Maturity
18th Dec 20132:35 pmRNSHolding(s) in Company
5th Dec 20134:36 pmRNSHolding(s) in Company
3rd Dec 20137:00 amRNSConversion of Warrants and Total Voting Rights
3rd Dec 20137:00 amRNSBlocklisting Interim Review
2nd Dec 20137:00 amRNSRefinancing Update
29th Nov 20137:00 amRNSInterim Preference Share Dividend
7th Nov 20134:36 pmRNSSale Completion of Three Assets in Amiens, France
11th Oct 20135:15 pmRNSDebt Reduction
4th Oct 20132:44 pmRNSInformation Notice
5th Aug 20137:00 amRNSAnnouncement of NAV and IMS
2nd Aug 20133:47 pmRNSHolding(s) in Company
29th Jul 20137:00 amRNSSale Completion of Chateauneuf, France
26th Jul 20137:00 amRNSOver-Amortization of Debt
11th Jul 201311:56 amRNSHolding(s) in Company
21st Jun 201311:31 amRNSHolding(s) in Company
20th Jun 20134:37 pmRNSHolding(s) in Company
18th Jun 201310:19 amRNSHolding(s) in Company
5th Jun 20135:10 pmRNSConversion of Warrants and Total Voting Rights
5th Jun 20135:07 pmRNSBlocklisting Interim Review
5th Jun 20134:40 pmRNSSecond Price Monitoring Extn
5th Jun 20134:35 pmRNSPrice Monitoring Extension
31st May 20137:00 amRNSInterim Preference Share Dividend
31st May 20137:00 amRNSHalf Yearly Report
7th May 20134:40 pmRNSSecond Price Monitoring Extn
7th May 20134:35 pmRNSPrice Monitoring Extension
1st May 20137:00 amRNSSale of Office Asset in Belgium
25th Apr 20137:00 amRNSBoard Change
12th Apr 20134:40 pmRNSSecond Price Monitoring Extn
12th Apr 20134:35 pmRNSPrice Monitoring Extension
3rd Apr 20134:59 pmRNSInformation Notice
25th Mar 20134:40 pmRNSSecond Price Monitoring Extn
25th Mar 20134:35 pmRNSPrice Monitoring Extension
20th Mar 20135:12 pmRNSHolding(s) in Company
20th Mar 20134:35 pmRNSPrice Monitoring Extension
15th Mar 20134:40 pmRNSSecond Price Monitoring Extn
15th Mar 20134:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.